Martin Fisher

Summary

Affiliation: Royal Sussex County Hospital
Country: UK

Publications

  1. ncbi request reprint Acute hepatitis C: changing epidemiology and association with HIV infection
    Nick Brejt
    Lawson Unit, The Royal Sussex County Hospital, Eastern Road, Brighton, East Sussex BN52 5BE, UK
    J HIV Ther 12:3-6. 2007
  2. ncbi request reprint Brief communication: rituximab in HIV-associated multicentric Castleman disease
    Mark Bower
    Department of Oncology, Imperial College, The Chelsea and Westminster Hospital, Barts and The London NHS Trust, and Queen Mary s University, London, United Kingdom
    Ann Intern Med 147:836-9. 2007
  3. ncbi request reprint Serological testing algorithm shows rising HIV incidence in a UK cohort of men who have sex with men: 10 years application
    Martin Fisher
    Department of HIV and Genitourinary Medicine, Brighton and Sussex University Hospitals, Eastern Road, Brighton, BN2 5BE, UK
    AIDS 21:2309-14. 2007
  4. pmc NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
    Stephen Brown
    AIDS Research Alliance, Los Angeles, CA, USA
    AIDS Res Ther 10:5. 2013
  5. ncbi request reprint UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure
    Martin Fisher
    Department of Genitourinary Medicine, Royal Sussex County Hospital, Brighton, UK
    Int J STD AIDS 17:81-92. 2006
  6. doi request reprint Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach
    Martin Fisher
    HIV GUM Research Department, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
    AIDS 24:1739-47. 2010
  7. ncbi request reprint Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections
    David Pao
    Department of GU Medicine, Brighton and Sussex University Hospitals, Brighton, UK
    AIDS 19:85-90. 2005
  8. ncbi request reprint Long-term persistence of primary genotypic resistance after HIV-1 seroconversion
    David Pao
    Royal Sussex County Hospital, Brighton, United Kingdom
    J Acquir Immune Defic Syndr 37:1570-3. 2004
  9. doi request reprint Potential impact of early antiretroviral therapy on transmission
    David Pao
    HIV GUM Research Department, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
    Curr Opin HIV AIDS 4:215-21. 2009
  10. doi request reprint A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals
    Martin Fisher
    Elton John Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom
    J Acquir Immune Defic Syndr 51:562-8. 2009

Detail Information

Publications59

  1. ncbi request reprint Acute hepatitis C: changing epidemiology and association with HIV infection
    Nick Brejt
    Lawson Unit, The Royal Sussex County Hospital, Eastern Road, Brighton, East Sussex BN52 5BE, UK
    J HIV Ther 12:3-6. 2007
    ....
  2. ncbi request reprint Brief communication: rituximab in HIV-associated multicentric Castleman disease
    Mark Bower
    Department of Oncology, Imperial College, The Chelsea and Westminster Hospital, Barts and The London NHS Trust, and Queen Mary s University, London, United Kingdom
    Ann Intern Med 147:836-9. 2007
    ..Many therapeutic approaches in small series of patients have proved largely unsuccessful to date...
  3. ncbi request reprint Serological testing algorithm shows rising HIV incidence in a UK cohort of men who have sex with men: 10 years application
    Martin Fisher
    Department of HIV and Genitourinary Medicine, Brighton and Sussex University Hospitals, Eastern Road, Brighton, BN2 5BE, UK
    AIDS 21:2309-14. 2007
    ..To investigate whether combining clinical data with the serological testing algorithm for recent HIV seroconversion (STARHS) reliably identifies otherwise unrecognized recent infections and observe their trends...
  4. pmc NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
    Stephen Brown
    AIDS Research Alliance, Los Angeles, CA, USA
    AIDS Res Ther 10:5. 2013
    ..Data from two phase III, double-blind studies were integrated to further analyze the efficacy and safety of NGX-4010 and explore the effect of demographic and baseline factors on NGX-4010 treatment in HIV-DSP...
  5. ncbi request reprint UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure
    Martin Fisher
    Department of Genitourinary Medicine, Royal Sussex County Hospital, Brighton, UK
    Int J STD AIDS 17:81-92. 2006
    ..Throughout the document, consideration is given to the place of PEPSE within the broader context of HIV prevention strategies and sexual health...
  6. doi request reprint Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach
    Martin Fisher
    HIV GUM Research Department, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
    AIDS 24:1739-47. 2010
    ..To identify biological factors associated with HIV transmission in men who have sex with men (MSM)...
  7. ncbi request reprint Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections
    David Pao
    Department of GU Medicine, Brighton and Sussex University Hospitals, Brighton, UK
    AIDS 19:85-90. 2005
    ..To study primary HIV-1 infections (PHI) using molecular and epidemiological approaches in order to assess correlates of transmission in this population...
  8. ncbi request reprint Long-term persistence of primary genotypic resistance after HIV-1 seroconversion
    David Pao
    Royal Sussex County Hospital, Brighton, United Kingdom
    J Acquir Immune Defic Syndr 37:1570-3. 2004
    ....
  9. doi request reprint Potential impact of early antiretroviral therapy on transmission
    David Pao
    HIV GUM Research Department, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
    Curr Opin HIV AIDS 4:215-21. 2009
    ..We will focus on the biological plausibility and behavioural factors associated with HAART use and interventions that might influence such a strategy...
  10. doi request reprint A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals
    Martin Fisher
    Elton John Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom
    J Acquir Immune Defic Syndr 51:562-8. 2009
    ..Long-term antiretroviral therapy dramatically reduces HIV-related morbidity and mortality but is also associated with metabolic and morphological changes and requires high levels of adherence...
  11. pmc Multicentre RCT and economic evaluation of a psychological intervention together with a leaflet to reduce risk behaviour amongst men who have sex with men (MSM) prescribed post-exposure prophylaxis for HIV following sexual exposure (PEPSE): a protocol
    Carrie Llewellyn
    Brighton and Sussex Medical School, Brighton, UK
    BMC Infect Dis 12:70. 2012
    ..A secondary aim of this research is to examine the impact of the intervention on adherence to PEP. This study will also provide estimates of the cost-effectiveness of the intervention...
  12. ncbi request reprint Immunological changes during treatment interruptions: risk factors and clinical sequelae
    Mary B Poulton
    Brighton Health Care NHS Trust, Royal Sussex County Hospital, Brighton, East Sussex BN2 5BE, UK
    AIDS 17:126-8. 2003
  13. ncbi request reprint Preexposure prophylaxis for HIV infection: it's not as easy as ABC
    Martin Fisher
    Department of HIV Genitourinary Medicine, Brighton and Sussex University Hospitals, NHS Trust, Brighton, UK
    Curr Opin Infect Dis 20:1-2. 2007
  14. ncbi request reprint Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice
    Sara Louise Day
    Brighton and Sussex University Hospitals, National Health Service Trust, Brighton, Sussex, United Kingdom
    J Acquir Immune Defic Syndr 38:301-4. 2005
    ..The etiology of HP seems to be multifactorial and unrelated to TDF or renal dysfunction. This questions the utility of routine phosphate testing, in isolation, in TDF recipients...
  15. doi request reprint Why some MSM present late for HIV testing: a qualitative analysis
    Lucy Dowson
    Brighton and Sussex Medical School, Brighton, UK
    AIDS Care 24:204-9. 2012
    ..Population-targeted health promotion alongside a more proactive approach by healthcare professionals and making HIV testing more convenient and accessible may result in earlier testing...
  16. pmc Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study
    Collins C Iwuji
    Lawson Unit, Department of HIV Genitourinary Medicine, Brighton and Sussex University Hospitals NHS Trust, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK
    BMC Public Health 13:397. 2013
    ..We examined factors associated with late presentation of HIV using the new European consensus definition (CD4 cell count <350 cells/mm3) and mortality...
  17. doi request reprint Home sampling kits for sexually transmitted infections: preferences and concerns of men who have sex with men
    Sonali Wayal
    Division of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK
    Cult Health Sex 13:343-53. 2011
    ..Home sampling kits could be a viable alternative to meet the increasing demand for sexual health services, but to improve the home sampling kit uptake the method of service provision must be culturally sensitive and acceptable...
  18. ncbi request reprint Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count
    Andrew N Phillips
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
    AIDS 21:1717-21. 2007
    ..To assess the absolute rate of AIDS and death in antiretroviral therapy (ART)-naive patients with a high CD4 cell count. Such information would be helpful in the design of a trial investigating early initiation of ART...
  19. ncbi request reprint Survival following HIV infection of a cohort followed up from seroconversion in the UK
    Fiona M Ewings
    MRC Clinical Trials Unit, London, UK
    AIDS 22:89-95. 2008
    ..To estimate changes over calendar time in survival following HIV seroconversion in the era of HAART and to provide updated survival estimates...
  20. ncbi request reprint Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures
    Andrew A Benzie
    St Mary s Hospital, London, UK
    AIDS 21:1423-30. 2007
    ....
  21. ncbi request reprint Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3
    Kholoud Porter
    Medical Research Council Clinical Trials Unit, London, United Kingdom
    J Acquir Immune Defic Syndr 47:202-5. 2008
    ....
  22. ncbi request reprint HIV and postexposure prophylaxis
    Paul Benn
    Department of Genitourinary Medicine, Mortimer Market Centre, Camden PCT, London
    Clin Med 8:319-22. 2008
  23. doi request reprint Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?
    Loveleen K Bansi
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Hampstead Campus, Rowland Hill Street, London, NW3 2PF, UK
    AIDS 22:349-56. 2008
    ..We investigated whether previous treatment interruptions are associated with a raised risk of viral rebound in individuals who have attained virological suppression...
  24. doi request reprint Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity
    Lorraine Sherr
    Department of Primary Care and Population Sciences, Royal Free University College Medical School, London, UK
    AIDS Care 20:442-8. 2008
    ..42, p=0.01). The softer markers of adherence are not usually measured in follow up and may account for variations in treatment responses. The complexity of adherence needs to be understood and addressed to maximise treatment efficacy...
  25. doi request reprint Sexual transmission of hepatitis C in MSM may not be confined to those with HIV infection
    Daniel Richardson
    J Infect Dis 197:1213-4, author reply 1214-5. 2008
  26. doi request reprint Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women
    Inmaculada Jarrin
    National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
    Am J Epidemiol 168:532-40. 2008
    ..74, 95% CI: 0.56, 0.98). Sex differences in HIV disease progression have become larger and statistically significant in the era of highly active antiretroviral therapy, supporting a stronger impact of health interventions among women...
  27. ncbi request reprint Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients
    Caroline A Sabin
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
    Antivir Ther 8:301-8. 2003
    ..New formulations of amprenavir, together with boosted regimens, may enhance the activity in the presence of protease inhibitor-resistant virus...
  28. ncbi request reprint Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework
    Robert Horne
    Centre for Behavioural Medicine, Department of Policy and Practice, The School of Pharmacy, University of London, and Brighton University Hospital, National Health Service Trust, The Lawson Unit, United Kingdom
    J Acquir Immune Defic Syndr 45:334-41. 2007
    ..To test the utility of the necessity-concerns framework in predicting highly active antiretroviral therapy (HAART) uptake and adherence...
  29. ncbi request reprint Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours
    Mark Danta
    UCL Institute of Hepatology, London, UK
    AIDS 21:983-91. 2007
    ..To characterize the mode of hepatitis C virus (HCV) transmission in a recent epidemic of acute HCV in HIV-infected individuals using linked molecular and clinical epidemiological studies...
  30. ncbi request reprint A balance of risks for the treatment of the chronically HIV-infected asymptomatic individual
    Ceri Watson
    Brighton University Hospital
    Clin Med 3:212-6. 2003
  31. ncbi request reprint A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study)
    Chloe Orkin
    The St Stephen s Centre, The Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH
    J Antimicrob Chemother 55:246-51. 2005
    ..Research is required on the effectiveness of quadruple therapy in comparison to this and the relative effectiveness of specific highly active antiretroviral therapy (HAART) combinations...
  32. ncbi request reprint Brief report: two-year outcome of a multidrug regimen in patients who did not respond to a protease inhibitor regimen
    Mike Youle
    Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, London, United Kingdom
    J Acquir Immune Defic Syndr 29:58-61. 2002
    ..Thus, a substantial proportion of patients who had failed to respond virologically to PI-containing regimens can achieve profound and sustained virologic suppression with a multidrug regimen...
  33. ncbi request reprint Successive switching of antiretroviral therapy is associated with high psychological and physical burden
    Lorraine Sherr
    Royal Free and University College Medical School, London, UK
    Int J STD AIDS 18:700-4. 2007
    ..A holistic approach is needed to understand the psychological effects of such switches if lifelong treatment is to be maintained and those on antiretroviral treatment are to attain good quality of life and minimize symptom burden...
  34. doi request reprint Suicidal ideation in UK HIV clinic attenders
    Lorraine Sherr
    Royal Free and University College Medical School, London, UK
    AIDS 22:1651-8. 2008
    ..Although new treatments have changed prognosis, they also bring new challenges. This study measured suicidal ideation in HIV clinic attenders in the United Kingdom (London/Southeast) and explored associated factors...
  35. pmc Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial
    William Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    J Acquir Immune Defic Syndr 49:142-50. 2008
    ..To compare the HIV transmission risk among patients randomized to episodic versus continuous antiretroviral therapy...
  36. ncbi request reprint Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication
    Wolfgang Stöhr
    MRC Clinical Trials Unit, London, UK
    Antivir Ther 13:675-85. 2008
    ..The aim of this study was to examine factors influencing plasma concentration of efavirenz and nevirapine...
  37. pmc Maraviroc for previously treated patients with R5 HIV-1 infection
    Roy M Gulick
    Weill Cornell Medical College, New York, NY 10065, USA
    N Engl J Med 359:1429-41. 2008
    ..CC chemokine receptor 5 antagonists are a new class of antiretroviral agents...
  38. doi request reprint Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
    Gerd Fatkenheuer
    Universitätsklinik Köln, Cologne, Germany
    N Engl J Med 359:1442-55. 2008
    ....
  39. ncbi request reprint Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression
    Andrew N Phillips
    Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
    AIDS 18:1795-804. 2004
    ..It is currently unclear whether the tendency for viral rebound in patients with viral load < 50 copies/ml differs according to the specific drug regimen being used...
  40. ncbi request reprint Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters
    Krishnan Bhaskaran
    Medical Research Council Clinical Trials Unit, London, UK
    AIDS 18:1471-3. 2004
    ..The virological and host determinants of this possible phenomenon are worth further exploration...
  41. ncbi request reprint Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART
    Robert Horne
    Centre for Health Care Research, Post Graduate Medical School, University of Brighton, Mayfield House, Falmer, Brighton BN1 9PH, UK
    Int J STD AIDS 15:38-44. 2004
    ..These preliminary findings suggest that patients' perceptions of HAART are important determinants of adherence with implications for future research and clinical practice...
  42. ncbi request reprint Primary HIV Infection, phylogenetics, and antiretroviral prevention
    Deenan Pillay
    J Infect Dis 195:924-6. 2007
  43. ncbi request reprint Joint-working. Worlds apart
    Pat Gordon
    Department of Organisational Research, London School of Economics
    Health Serv J 113:28-9. 2003
    ..Knowledge of each other's worlds was initially poor. Annual structured visits between PCTs and local authorities should be encouraged...
  44. ncbi request reprint A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis
    Jacob Lalezari
    Quest Clinical Research, San Francisco, California 94115, USA
    J Acquir Immune Defic Syndr 30:392-400. 2002
    ..Other than a higher than expected frequency of oral candidiasis (17%), no clinical toxicities or laboratory abnormalities occurred during treatment with valganciclovir that have not been observed during treatment with ganciclovir...
  45. ncbi request reprint Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression
    Catharina E A Lindenburg
    The Municipal Health Service of Amsterdam, Cluster Infectious Diseases, Amsterdam, The Netherlands
    Vaccine 20:2343-7. 2002
    ..98). In conclusion, therapeutic vaccination with p24-VLP is not related to slower HIV-1 disease progression...
  46. ncbi request reprint Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz
    Frank van Leth
    Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Antivir Ther 9:721-8. 2004
    ..To assess whether differences in safety profiles between nevirapine (NVP) and efavirenz (EFV), as observed in the 2NN study, translated into differences in 'health related quality of life' (HRQoL)...
  47. ncbi request reprint Clinical standards for the screening and management of acquired syphilis in HIV-positive adults
    Rak Nandwani
    The Sandyford Initiative, Glasgow and Brownlee Centre, Gartnavel General Hospital, Glasgow, UK
    Int J STD AIDS 17:588-93. 2006
    ..594-606]. Many of the recommendations remain in force and therefore the original document is published in full here...
  48. ncbi request reprint An open-label, randomized comparative pilot study of a single-class quadruple therapy regimen versus a 2-class triple therapy regimen for individuals initiating antiretroviral therapy
    Graeme Moyle
    Chelsea and Westminster Hospital, London, UK
    Antivir Ther 11:73-8. 2006
    ..To examine the antiviral potency and tolerability profile of a single-class four drug (quadruple) nucleoside reverse transcriptase inhibitor (NRTI) regimen compared with a 2-class standard-of-care regimen...
  49. ncbi request reprint Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study
    Andrew N Phillips
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
    Lancet 370:1923-8. 2007
    ..We estimated the proportion of patients who had extensive triple-class failure during long-term follow-up and examined characteristics associated with an increased rate of failure...
  50. ncbi request reprint The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study
    Colette J Smith
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom
    J Infect Dis 192:1387-97. 2005
    ....
  51. ncbi request reprint A case of multidrug resistant primary HIV infection with delayed CD4 T-cell count decline despite low viral load, treated with interleukin-2
    David Pao
    AIDS 20:1564-5. 2006
  52. doi request reprint Late diagnosis of HIV infection: major consequences and missed opportunities
    Martin Fisher
    Curr Opin Infect Dis 21:1-3. 2008
  53. ncbi request reprint Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice
    Andrew N Phillips
    AIDS 19:487-94. 2005
    ..Little is known about the long term risk of development of HIV-1 drug resistance for patients starting antiretroviral therapy (ART) with three or four drug regimens in routine clinical practice...
  54. doi request reprint TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals
    Brian Angus
    Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK
    AIDS 22:737-40. 2008
    ..We aimed to see if structured treatment interruption (STI) could be supported safely with the use of two cycles of IL-2 (4.5 MIU q12h subcutaneously 5 days) before STI to prolong the time before therapy restarted...
  55. doi request reprint Predictors of renal outcome in HIV-associated nephropathy
    Frank A Post
    Academic Dept of HIV GUM, King s College London School of Medicine at Guy s, King s College, London, United Kingdom
    Clin Infect Dis 46:1282-9. 2008
    ..This study was performed to study the epidemiology of HIVAN in a predominantly black African population and the impact of highly active antiretroviral therapy and other factors on the development of end-stage renal disease...
  56. pmc Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study
    Caroline A Sabin
    Department of Primary Care and Population Sciences, Royal Free and UC Medical School, London NW3 2PF
    BMJ 330:695. 2005
    ....
  57. ncbi request reprint Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Gillian L Dean
    St Thomas Hospital, London, UK
    AIDS 16:75-83. 2002
    ..To assess the risks and benefits of administering highly active antiretroviral therapy (HAART) during the treatment of tuberculosis (TB) in HIV-infected patients...
  58. ncbi request reprint Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations
    Mike Youle
    Royal Free Hospital Centre for HIV Medicine, Royal Free Hospital, London, UK
    HIV Clin Trials 7:86-96. 2006
    ..g., ENF) for triple-class-experienced patients...
  59. doi request reprint Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    Krishnan Bhaskaran
    MRC Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, United Kingdom
    JAMA 300:51-9. 2008
    ..Mortality among human immunodeficiency virus (HIV)-infected individuals has decreased dramatically in countries with good access to treatment and may now be close to mortality in the general uninfected population...